A hypothyroidism-specific hypertension risk prediction model incorporating age, serum creatinine, anion gap, and diabetes mellitus demonstrated robust discrimination, good calibration, and favorable clinical utility across training, testing, and external validation cohorts.
Key Findings
Results
Four variables — age, serum creatinine (SCr), anion gap (AG), and diabetes mellitus (DM) — were identified as the key predictors of hypertension risk in patients with hypothyroidism.
Predictors were selected using regression-based approaches in the derivation cohort.
The combination was described as 'a clinically interpretable risk profile reflecting vascular aging, renal vulnerability, and metabolic dysregulation.'
All four variables are routinely available clinical variables, supporting practical implementation.
The predictors span multiple pathophysiological domains: cardiovascular (age), renal (SCr), acid-base/metabolic (AG), and metabolic disease (DM).
Results
The prediction model demonstrated robust discrimination, good calibration, and favorable clinical utility across training, testing, and external validation cohorts.
The model was evaluated in internal validation, external validation, and subgroup analyses.
Performance was described as 'robust discrimination, good calibration, and favorable clinical utility.'
External validation was conducted using an independent population-based cohort distinct from the hospital-based derivation cohort.
The study design was a retrospective multicohort study with both a hospital-based cohort and an independent external population-based cohort.
Methods
The study used a retrospective multicohort design with patients identified from a hospital-based derivation cohort and an independent external population-based cohort.
Eligible participants were identified according to predefined diagnostic criteria for hypothyroidism.
Individuals with missing key clinical variables or incomplete outcome information were excluded.
Candidate predictors were selected using regression-based approaches in the derivation cohort.
The model was subsequently evaluated in internal and external validation cohorts to assess generalizability.
Background
Validated tools for hypertension risk stratification specifically designed for patients with hypothyroidism were lacking prior to this study.
Hypothyroidism was described as 'a multisystem endocrine disorder involving cardiovascular, renal, and metabolic alterations beyond thyroid hormone deficiency.'
The gap identified was the absence of 'validated tools for hypertension (HTN) risk stratification specifically designed for patients with hypothyroidism.'
The study aimed to fill this gap by developing a hypothyroidism-specific HTN prediction model incorporating routinely available clinical variables.
Conclusions
The authors conclude that the model provides a practical approach for individualized cardiovascular risk stratification and supports precision endocrine medicine in hypothyroid patients.
The model was described as providing 'a practical approach for individualized cardiovascular risk stratification.'
The authors frame the tool as supporting 'the application of precision endocrine medicine.'
The risk profile was characterized as 'disease specific' and externally validated in patients with hypothyroidism.
Subgroup analyses were conducted as part of the validation framework.
What This Means
This research suggests that a simple four-variable tool — incorporating a patient's age, kidney function marker (serum creatinine), a blood chemistry measure called anion gap, and whether they have diabetes — can predict the risk of developing high blood pressure (hypertension) in people who already have hypothyroidism (an underactive thyroid). The researchers developed this prediction model using patient data from a hospital and then tested it in a completely separate, independent group of patients to confirm it worked reliably. The model showed good accuracy in distinguishing who was and was not at risk of hypertension across all the groups tested.
Hypothyroidism affects multiple body systems beyond just thyroid hormone levels, including the heart, kidneys, and metabolism, and people with this condition face elevated cardiovascular risks. Before this study, there were no validated tools specifically designed to assess hypertension risk in this patient population. The four predictors chosen reflect different aspects of health — aging of blood vessels (age), kidney stress (creatinine), metabolic imbalance (anion gap), and metabolic disease (diabetes) — all of which are routinely measured in clinical practice, making the tool easy to use without additional testing.
This research suggests that clinicians caring for patients with hypothyroidism could use this type of risk profile to identify which patients are most likely to develop hypertension, potentially allowing for earlier monitoring or intervention. The external validation in an independent population-based cohort strengthens confidence that the model may generalize beyond the original study setting, though further prospective studies would be needed to confirm its real-world clinical impact.
Lin L, Chen L, Yu K, Li Q, Huang J, Li L, et al.. (2026). Development and external validation of a risk prediction model for hypertension among individuals with established hypothyroidism.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1945343